HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael R Pranzatelli Selected Research

Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)

1/2018Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.
1/2018Corrigendum to "Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome" [Pediatric Neurology 73 (2017) 48-56].
1/2018Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS.
1/2018Rituximab, IVIg, and Tetracosactide (ACTH1-24) Combination Immunotherapy ("RITE-CI") for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations.
8/2017Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome.
1/2014CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.
10/2013CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsive.
5/2013CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.
3/2013Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders.
3/2013Response to correspondence on "active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome".
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael R Pranzatelli Research Topics

Disease

28Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
01/2018 - 11/2002
11Neuroinflammatory Diseases
07/2018 - 07/2011
8Neoplasms (Cancer)
01/2018 - 11/2002
6Nervous System Diseases (Neurological Disorders)
10/2017 - 03/2009
2Ataxia (Dyssynergia)
01/2018 - 11/2002
2Central Nervous System Diseases (CNS Diseases)
10/2008 - 08/2005
2Myoclonus (Nocturnal Myoclonus)
09/2006 - 03/2003
2Neuroblastoma
12/2004 - 11/2002
1Adenocarcinoma
01/2018
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2018
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2018
1Lymphopenia (Lymphocytopenia)
01/2018
1Tourette Syndrome (Tourette's Syndrome)
01/2017
1Infections
05/2016
1Gliosis
01/2014
1Memory Disorders (Memory Loss)
09/2012
1Seizures (Absence Seizure)
09/2012
1Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
09/2012
1Ganglioneuroblastoma
06/2012
1Infantile Spasms (West Syndrome)
11/2011
1Body Weight (Weight, Body)
07/2010
1Communicable Diseases (Infectious Diseases)
10/2008
1Ocular Motility Disorders (Convergence Insufficiency)
09/2006
1Sialorrhea
09/2006
1Gait Ataxia
09/2006
1Neurologic Manifestations (Neurological Manifestations)
12/2004
1Movement Disorders (Movement Disorder)
03/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2003
1Atrophy
11/2002

Drug/Important Bio-Agent (IBA)

12Rituximab (Mabthera)FDA Link
01/2018 - 01/2005
9Intravenous Immunoglobulins (IVIG)FDA Link
07/2018 - 11/2002
8Adrenocorticotropic Hormone (ACTH)FDA Link
07/2018 - 08/2005
7Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2004
7ChemokinesIBA
01/2018 - 05/2013
6CytokinesIBA
01/2018 - 03/2013
4Oligoclonal BandsIBA
01/2018 - 07/2011
3AutoantibodiesIBA
05/2016 - 11/2002
3SteroidsIBA
10/2013 - 08/2005
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2018 - 07/2012
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 08/2017
2AntibodiesIBA
09/2012 - 11/2002
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018
1InflammasomesIBA
01/2018
1Chemokine ReceptorsIBA
01/2018
1Cosyntropin (Cortrosyn)FDA LinkGeneric
01/2018
1EnzymesIBA
01/2018
1Cell Adhesion MoleculesIBA
01/2018
1Lipopolysaccharide ReceptorsIBA
10/2017
1ofatumumabFDA Link
06/2012
1Chemotactic FactorsIBA
02/2012
1Therapeutic UsesIBA
11/2011
1NeuropeptidesIBA
11/2011
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
03/2009
1B-Cell Activating FactorIBA
10/2008
1Monoclonal AntibodiesIBA
09/2006
1Trazodone (Trittico)FDA LinkGeneric
09/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2005
1Hydrocortisone (Cortisol)FDA LinkGeneric
08/2005
1NeopterinIBA
12/2004
1AntioxidantsIBA
03/2003
1Nerve Growth Factors (Neurotrophins)IBA
03/2003
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2002

Therapy/Procedure

15Immunotherapy
07/2018 - 07/2004
11Therapeutics
07/2018 - 03/2003
4Drug Therapy (Chemotherapy)
07/2012 - 07/2004
1Plasma Exchange
06/2012
1Aftercare (After-Treatment)
03/2009
1Lasers (Laser)
11/2004